NCT03887026View on ClinicalTrials.gov

Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

May 18, 2019

Study Completion Date

May 29, 2019

Conditions
Allergic RhinitisAllergic Rhinoconjunctivitis
Interventions
DRUG

Norketotifen

Norketotifen oral capsule

DRUG

Placebo

Placebo oral capsule

Trial Locations (1)

78229

Biogenics Research Chamber, San Antonio

Sponsors
All Listed Sponsors
lead

Emergo Therapeutics, Inc.

INDUSTRY